| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
3,375 |
2,489 |
$3.50M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
2,386 |
1,848 |
$2.24M |
| J2778 |
Injection, ranibizumab, 0.1 mg |
3,369 |
2,698 |
$1.48M |
| 92134 |
|
21,329 |
18,542 |
$778K |
| Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg |
3,148 |
2,466 |
$655K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
15,946 |
12,176 |
$612K |
| 92201 |
|
9,461 |
8,721 |
$183K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,264 |
3,957 |
$176K |
| 76512 |
|
3,993 |
2,545 |
$140K |
| 92250 |
|
3,233 |
2,840 |
$99K |
| 92235 |
|
2,349 |
2,165 |
$95K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,416 |
2,766 |
$84K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
751 |
703 |
$62K |
| 92020 |
|
1,770 |
1,655 |
$55K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
801 |
753 |
$33K |
| 92060 |
|
759 |
718 |
$23K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
632 |
533 |
$22K |
| J3490 |
Unclassified drugs |
17 |
13 |
$7K |
| 92226 |
|
726 |
455 |
$6K |
| J9035 |
Injection, bevacizumab, 10 mg |
29 |
26 |
$3K |
| 92242 |
|
48 |
38 |
$2K |
| J2403 |
Chloroprocaine hcl ophthalmic, 3% gel, 1 mg |
278 |
224 |
$2K |
| 92202 |
|
20 |
14 |
$217.04 |